Latest filing published 21 Nov 2008 for ANGIOTECH PHARMACEUTICALS INC, €160.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
David T. Howard: trading record in brief
David T. Howard discloses dealings in Angiotech Pharmaceuticals Inc to SEC (Form 4). The record holds 4 filings, all for trades on 19 November 2008.
Purchases make up the whole of the open-market record (4 purchases, €13k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
In size, the median ticket on the buying side is €3,215.
The newest entry dates from 21 November 2008: an open-market purchase of €160, in Angiotech Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David T. Howard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$0.20Common StockSEC:0001096481-08-000003:0Canonical exit: 17 Feb 2009 (T+90)
- 49,000 shares@ US$0.16Common StockSEC:0001096481-08-000003:1Canonical exit: 17 Feb 2009 (T+90)
2 of 2 declarations